CSBio CatNo |
Product |
Sequence |
synonym |
CAS Number |
Chemical Structure |
MW |
Disease Category |
Quantity |
CS9550 |
Arg28(γ-Glu-palmitoyl), Liraglutide
|
Sequence
|
|
|
C193H302N44O55 |
3939.02 |
|
|
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg(γ-Glu-palmitoyl)-Gly-Arg-Gly |
CS9551 |
Arg30(γ-Glu-palmitoyl), Liraglutide
|
Sequence
|
|
|
C193H302N44O55 |
3939.02 |
|
|
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg(γ-Glu-palmitoyl)-Gly |
CS9553 |
Lys20, Arg30(γ-Glu-palmitoyl), Liraglutide
|
Sequence
|
|
|
C172H265N43O51 |
3571.38 |
|
|
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg(γ-Glu-palmitoyl)-Gly |
CS9554 |
Lys40(NOTA), Exendin-4
|
Sequence
|
|
|
|
4600.22 |
|
|
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys(NOTA)-NH2 |
CS9555 |
Lys40(DOTA), Exendin-4
|
Sequence
|
|
|
|
4701.45 |
|
|
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys(DOTA)-NH2 |
CS9556 |
(D-Ser)4, Triptorelin
|
Sequence
|
|
102992-39-2 |
C64H82N18O13 |
1311.45 |
|
|
Glp-His-Trp-(D-Ser)-Tyr-(D-Trp)-Leu-Arg-Pro-Gly-NH2 |
CS9557 |
(D-Tyr)5, Triptorelin
|
Sequence
|
|
321709-35-7 |
C64H82N18O13 |
1311.45 |
|
|
Glp-His-Trp-Ser-(D-Tyr)-(D-Trp)-Leu-Arg-Pro-Gly-NH2 |
CS9558 |
Triptorelin acid
|
Sequence
|
|
|
C65H82N17O14 |
1312.5 |
|
|
Glp-His-Trp-Ser-Tyr-(D-Trp)-Leu-Arg-Pro-Gly |
CS9559 |
Glu1, Triptorelin
|
Sequence
|
|
|
C64H84N18O14 |
1329.4 |
|
|
Glu-His-Trp-Ser-Tyr-(D-Trp)-Leu-Arg-Pro-Gly-NH2 |
CS9560 |
JR11
|
Sequence
|
|
|
|
1303.82 |
|
|
Cpa-(D-Cys)-[Aph(Hor)]-[D-Aph(Cbm)]-Lys-Thr-Cys-(D-Tyr)-NH2 [Disulfide bond (D-Cys)2/Cys7] |
CS9562 |
Degarelix, acid
|
Sequence
|
|
|
|
|
|
|
Ac-(D-2-Nal)-(D-4-Cpa)-(D-3-Pal)-Ser-[4-Aph(Hor)]-[D-4-Aph(carbamoyl)]-Leu-Lys(Ipr)-Pro-(D-Ala) |
CS9565 |
(Des-Pro9), (D-Ala)10, Degarelix
|
Sequence
|
|
|
|
1463.5 |
|
|
Ac-(D-2-Nal)-(D-4-Cpa)-(D-3-Pal)-Ser-[4-Aph(Hor)]-[D-4-Aph(carbamoyl)]-Leu-Lys(Ipr)-NH2 |
CS9566 |
Kalata B1
|
Sequence
|
|
|
C117H179N35O30S6 |
2892.48 |
|
|
Cyclo(Gly-Leu-Pro-Val-Cys-Gly-Glu-Thr-Cys-Val-Gly-Gly-Thr-Cys-Asn-Thr-Pro-Gly-Cys-Thr-Cys-Ser-Trp-Pro-Val-Cys-Thr-Arg-Asn) (Disulfide bond Cys5/Cys19, Cys9/Cys21, Cys14/Cys26) |
CS9567 |
Lys(Dde)7, D-Lys(Dde)8, T140
|
Sequence
|
|
|
|
2365.48 |
|
|
Arg-Arg-Nal-Cys-Tyr-Cit-Lys(Dde)-[D-Lys(Dde)]-Pro-Tyr-Arg-Cit-Cys-Arg-NH2 (Disulfide bond Cys4/Cys13) |
CS9570 |
(Cys20, Lys28), Semaglutide
|
Sequence
|
|
|
C149H223N39O47S |
3344.87 |
|
|
His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Cys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
CS9571 |
(Ala2, Cys20, Lys28), Semaglutide
|
Sequence
|
|
|
C148H221N39O47S |
3330.83 |
|
|
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Cys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
CS9601 |
Dipeptide-2
|
Sequence
|
|
24587-37-9 |
MF:C16H21N3O3 |
303.36 |
|
|
Val-Trp-OH |
CS9602 |
Dipeptide-4
|
Sequence
|
|
24587-41-5 |
MF:C20H21N3O3 |
351 |
|
|
Phe-Trp-OH |
CS9603 |
Dipeptide-6
|
Sequence
|
|
18684-24-7 |
MF:C10H16N2O4 |
228.25 |
|
|
Pro-Hyp-OH |
CS9604 |
Dipeptide-9
|
Sequence
|
|
17105-15-6 |
MF:C11H21N3O5 |
275.3 |
|
|
Glu-Lys-OH |